A nurse is caring for a client who is experiencing acute alcohol withdrawal. The nurse should anticipate administering which of the following medications to the client to facilitate the withdrawal process?

Choice A rationale Varenicline is a nicotinic receptor partial agonist used for smoking cessation. It acts by reducing the craving and withdrawal symptoms associated with nicotine dependence. It has no primary role in managing the acute neurological and physiological symptoms characteristic of alcohol withdrawal, which involve GABAergic and glutamatergic dysregulation. Choice B rationale Clonidine is an alpha-2 adrenergic agonist primarily used to treat hypertension. In alcohol withdrawal, it can help alleviate some autonomic symptoms like tachycardia and hypertension by reducing sympathetic nervous system overactivity. However, it does not address the core neurological hyperexcitability and seizure risk inherent in severe withdrawal. Choice C rationale Methadone is a long-acting opioid agonist used for opioid dependence treatment and pain management. It works by binding to opioid receptors, alleviating withdrawal symptoms and blocking euphoric effects of other opioids. It has no direct therapeutic application for the neurochemical imbalances and acute physical symptoms of alcohol withdrawal. Choice D rationale Diazepam is a long-acting benzodiazepine that enhances the effect of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter. In alcohol withdrawal, the central nervous system is hyperexcitable due to chronic alcohol-induced GABAergic downregulation. Diazepam's GABAergic potentiation effectively reduces neuronal excitability, preventing seizures and delirium.